Related Experiment Video
Updated: Jun 10, 2026
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
High-content screening of small compounds on human embryonic stem cells
Ivana Barbaric1, Paul J Gokhale, Peter W Andrews
1Centre for Stem Cell Biology, University of Sheffield, Western Bank, Sheffield S10 2TN, UK.
Abstract:
Human ES (embryonic stem) cells and iPS (induced pluripotent stem) cells have been heralded as a source of differentiated cells that could be used in the treatment of degenerative diseases, such as Parkinson's disease or diabetes. Despite the great potential for their use in regenerative therapy, the challenge remains to understand the basic biology of these remarkable cells, in order to differentiate them into any functional cell type. Given the scale of the task, high-throughput screening of agents and culture conditions offers one way to accelerate these studies. The screening of small-compound libraries is particularly amenable to such high-throughput methods. Coupled with high-content screening technology that enables simultaneous assessment of multiple cellular features in an automated and quantitative way, this approach is proving powerful in identifying both small molecules as tools for manipulating stem cell fates and novel mechanisms of differentiation not previously associated with stem cell biology. Such screens performed on human ES cells also demonstrate the usefulness of human ES/iPS cells as cellular models for pharmacological testing of drug efficacy and toxicity, possibly a more imminent use of these cells than in regenerative medicine.
Insights
High-throughput screening of small compounds accelerates the study of human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells. This approach identifies novel differentiation mechanisms and tools for stem cell manipulation and drug testing.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Pharmacological research
Background:
- Human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells hold promise for treating degenerative diseases.
- Understanding stem cell differentiation is crucial for regenerative therapy.
- High-throughput screening methods are needed to accelerate research in this field.
Purpose of the Study:
- To accelerate the study of human ES and iPS cell differentiation.
- To identify small molecules that can manipulate stem cell fates.
- To discover novel differentiation mechanisms and assess drug efficacy/toxicity.
Main Methods:
- High-throughput screening of small-compound libraries.
- High-content screening technology for automated, quantitative assessment of cellular features.
- Application of these methods to human ES cells.
Main Results:
- Identification of small molecules as tools for manipulating stem cell fates.
- Discovery of novel mechanisms of differentiation.
- Demonstration of human ES/iPS cells as models for pharmacological testing.
Conclusions:
- High-throughput and high-content screening are powerful approaches for stem cell research.
- These methods can identify tools and mechanisms for stem cell differentiation.
- Human ES/iPS cells are valuable for drug efficacy and toxicity testing, potentially preceding regenerative medicine applications.
